Patent ID: 7084122

Claim:
A method of treating or alleviating at least one inflammatory condition causing chemotaxis of mammal leucocytes in a mammal in need therefore, said inflammatory condition is arthritis or an inflammatory bowel disease, said method comprising the step of administering a dosage of from 0.005–20 mg/kg body weight per day of a medicament comprising an isolated compound of the formula I: wherein R and R′ independently are selected from hydrogen, C 10-24 -alkyl, and C 10-24 -acyl, said alkyl and acyl groups having 0 to 5 unsaturated bonds, and R 1 , R 2 , R 3 and R 4 independently are selected from hydrogen and glycoside moieties, wherein the glycoside moieties are either mono- or disaccharide moieties; with the first proviso that not both of R and R′ are hydrogen, and with the second proviso that none of R and R′ is eicosapentaenoyl, to the body of said mammal, wherein said mammal is selected from the group consisting of humans as well as domestic or farm animals.